Epilepsy Trial, Recruiting NCT06263920 Sponsor: Lancashire Teaching Hospitals NHS Foundation Trust Condition: Epilepsy
Back to Epilepsy

Epilepsy Trial, Recruiting

NCT06263920
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

If you have had a seizure or epilepsy diagnosis (Case group):

  • You have been diagnosed with epilepsy of unknown cause, or have had a first seizure, after the age of 18.
  • Your diagnosis was confirmed at a specialist neurology centre.
  • Places may be limited to the first 150 patients per year in this group if demand is high.

If you have migraines (Control group):

  • You have an established diagnosis of migraine.
  • You may or may not be taking medications that also happen to treat epilepsy.

Who may not be able to join:

If you have had a seizure or epilepsy diagnosis (Case group):

  • Your seizures have a known physical cause, such as a brain tumour, stroke (not including mini-strokes), brain injury from lack of oxygen, head trauma, or a blood vessel or brain development abnormality.

If you are in the migraine group (Control group):

  • You have been diagnosed with epilepsy or have had a confirmed seizure.
  • Your condition is linked to a known physical cause such as a brain tumour, stroke (not including mini-strokes), brain injury from lack of oxygen, or head trauma.

Please note: Having migraines does not prevent you from joining the seizure/epilepsy group (confirm with trial site).


Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Jasmine Wall, MB BChir, University of Lancaster

Phone: via switchboard

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Lancashire Teaching Hospitals NHS Foundation Trust
Registry
ClinicalTrials.gov
Start date
5 May 2022
Est. completion
12 January 2027

Where this trial is recruiting

🇬🇧 United Kingdom

Primary endpoints

At the time of onset, do people with late-onset epilepsy have higher prevalence of cerebrovascular disease risk factors compared to a control population?; Quality of Life - how of chronic illness is mediated

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov